Chagas disease: Immunology of the disease at a glance
- PMID: 34696979
- DOI: 10.1016/j.cytogfr.2021.10.001
Chagas disease: Immunology of the disease at a glance
Abstract
Chagas disease is an important neglected disease that affects 6-7 million people worldwide. The disease has two phases: acute and chronic, in which there are different clinical symptoms. Controlling the infection depends on innate and acquired immune responses, which are activated during the initial infection and are critical for host survival. Furthermore, the immune system plays an important role in the therapeutic success. Here we summarize the importance of the immune system cytokines in the pathology outcome, as well as in the treatment.
Keywords: Benzonidazole; Cytokines; Immune system; Neglected disease; Treatment; Trypanosoma cruzi.
Copyright © 2021 Elsevier Ltd. All rights reserved.
Similar articles
-
Experimental Chagas disease in Balb/c mice previously vaccinated with T. rangeli. II. The innate immune response shows immunological memory: reality or fiction?Immunobiology. 2015 Mar;220(3):428-36. doi: 10.1016/j.imbio.2014.10.003. Epub 2014 Oct 30. Immunobiology. 2015. PMID: 25454810
-
The innate immune response to Trypanosoma cruzi infection.Microbes Infect. 2010 Jul;12(7):511-7. doi: 10.1016/j.micinf.2010.03.005. Epub 2010 Mar 27. Microbes Infect. 2010. PMID: 20348008 Review.
-
[Role of cytokines in resistance and pathology in Trypanosoma cruzi infection].Rev Argent Microbiol. 1996 Apr-Jun;28(2):99-109. Rev Argent Microbiol. 1996. PMID: 8768488 Review. Spanish.
-
Galectin-3 mediates survival and apoptosis pathways during Trypanosoma cruzi-host cell interplay.Exp Parasitol. 2020 Sep;216:107932. doi: 10.1016/j.exppara.2020.107932. Epub 2020 Jun 12. Exp Parasitol. 2020. PMID: 32535113
-
The role of Toll-like receptors and adaptive immunity in the development of protective or pathological immune response triggered by the Trypanosoma cruzi protozoan.Future Microbiol. 2011 Dec;6(12):1521-33. doi: 10.2217/fmb.11.122. Future Microbiol. 2011. PMID: 22122446 Review.
Cited by
-
Genome-wide association study for Chagas Cardiomyopathy identify a new risk locus on chromosome 18 associated with an immune-related protein and transcriptional signature.PLoS Negl Trop Dis. 2022 Oct 10;16(10):e0010725. doi: 10.1371/journal.pntd.0010725. eCollection 2022 Oct. PLoS Negl Trop Dis. 2022. PMID: 36215317 Free PMC article.
-
Trypanosoma cruzi DNA Polymerase β Is Phosphorylated In Vivo and In Vitro by Protein Kinase C (PKC) and Casein Kinase 2 (CK2).Cells. 2022 Nov 21;11(22):3693. doi: 10.3390/cells11223693. Cells. 2022. PMID: 36429121 Free PMC article.
-
Effect of B-NIPOx in Experimental Trypanosoma cruzi Infection in Mice.Int J Mol Sci. 2022 Dec 25;24(1):333. doi: 10.3390/ijms24010333. Int J Mol Sci. 2022. PMID: 36613783 Free PMC article.
-
Selenium, TGF-Beta and Infectious Endemic Cardiopathy: Lessons from Benchwork to Clinical Application in Chagas Disease.Biomolecules. 2022 Feb 23;12(3):349. doi: 10.3390/biom12030349. Biomolecules. 2022. PMID: 35327541 Free PMC article. Review.
-
Heterologous mRNA-protein vaccination with Tc24 induces a robust cellular immune response against Trypanosoma cruzi, characterized by an increased level of polyfunctional CD8+ T-cells.Curr Res Immunol. 2023 Jul 20;4:100066. doi: 10.1016/j.crimmu.2023.100066. eCollection 2023. Curr Res Immunol. 2023. PMID: 37534309 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical